Skip to main content

Peer Review reports

From: Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma

Original Submission
15 Jun 2021 Submitted Original manuscript
21 Jul 2021 Reviewed Reviewer Report
5 Sep 2021 Reviewed Reviewer Report - Otilia Kimpel
15 Nov 2021 Reviewed Reviewer Report - Enzo Lalli
23 Nov 2021 Author responded Author comments - Bin-Cheng Ren
Resubmission - Version 2
23 Nov 2021 Submitted Manuscript version 2
5 Dec 2021 Reviewed Reviewer Report - Enzo Lalli
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
8 Apr 2022 Editorially accepted
14 May 2022 Article published 10.1186/s12902-022-01017-3

You can find further information about peer review here.

Back to article page